Clinical Trials
27 trialsA Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
University of Southern California
Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors
Roswell Park Cancer Institute
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer Center
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
University of Chicago
Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
Vanderbilt University Medical Center
Communication Training in Promoting Employment Retention Among Cancer Patients
Virginia Commonwealth University
NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
Cancer Research UK
High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Yale University
Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer
University of Southern California
Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Sorafenib in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors
National Cancer Institute (NCI)
AFP464 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors
National Cancer Institute (NCI)
Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
National Cancer Institute (NCI)
Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies
Case Comprehensive Cancer Center
Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Benzoylphenylurea in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
National Cancer Institute (NCI)
Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
National Cancer Institute (NCI)
BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors
National Cancer Institute (NCI)
Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors
National Cancer Institute (NCI)
GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
Cancer Research UK
UCDCC#207
University of California, Davis
Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center
Vanderbilt University